Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 23

2.

Lisofylline causes rapid and prolonged suppression of serum levels of free fatty acids.

Bursten SL, Federighi D, Wald J, Meengs B, Spickler W, Nudelman E.

J Pharmacol Exp Ther. 1998 Jan;284(1):337-45.

PMID:
9435196
3.

Modulating phosphatidic acid metabolism decreases oxidative injury in rat lungs.

Guidot DM, Bursten SL, Rice GC, Chaney RB, Singer JW, Repine AJ, Hybertson BM, Repine JE.

Am J Physiol. 1997 Nov;273(5):L957-66. doi: 10.1152/ajplung.1997.273.5.L957.

PMID:
9374722
4.

Lisofylline prevents leak, but not neutrophil accumulation, in lungs of rats given IL-1 intratracheally.

Hybertson BM, Bursten SL, Leff JA, Lee YM, Jepson EK, Dewitt CR, Zagorski J, Cho HG, Repine JE.

J Appl Physiol (1985). 1997 Jan;82(1):226-32.

5.
6.

Accumulation of glucosylceramides in multidrug-resistant cancer cells.

Lavie Y, Cao H, Bursten SL, Giuliano AE, Cabot MC.

J Biol Chem. 1996 Aug 9;271(32):19530-6.

7.

An increase in serum C18 unsaturated free fatty acids as a predictor of the development of acute respiratory distress syndrome.

Bursten SL, Federighi DA, Parsons P, Harris WE, Abraham E, Moore EE Jr, Moore FA, Bianco JA, Singer JW, Repine JE.

Crit Care Med. 1996 Jul;24(7):1129-36.

PMID:
8674324
8.

Lipid signal transduction pathways in angiotensin II type 1 receptor-transfected fibroblasts.

Wen Y, Cabot MC, Clauser E, Bursten SL, Nadler JL.

Am J Physiol. 1995 Aug;269(2 Pt 1):C435-42.

PMID:
7653525
9.

Interleukin-1 stimulates phosphatidic acid-mediated phospholipase D activity in human mesangial cells.

Bursten SL, Harris WE.

Am J Physiol. 1994 Apr;266(4 Pt 1):C1093-104.

PMID:
8178956
10.

The 31-kDa precursor of interleukin 1 alpha is myristoylated on specific lysines within the 16-kDa N-terminal propiece.

Stevenson FT, Bursten SL, Fanton C, Locksley RM, Lovett DH.

Proc Natl Acad Sci U S A. 1993 Aug 1;90(15):7245-9.

11.

Myristyl acylation of the tumor necrosis factor alpha precursor on specific lysine residues.

Stevenson FT, Bursten SL, Locksley RM, Lovett DH.

J Exp Med. 1992 Oct 1;176(4):1053-62.

12.

Generation of phosphatidic acid and diacylglycerols following ligation of surface immunoglobulin in human B lymphocytes: potential role in PKC activation.

Valentine MA, Bursten SL, Harris WE, Draves KE, Pollok BA, Ostrowski J, Bomsztyk K, Clark EA.

Cell Immunol. 1992 May;141(2):373-87.

PMID:
1374290
13.
14.

Lipid A activation of glomerular mesangial cells: mimicry of the bioactive lipid, phosphatidic acid.

Bursten SL, Harris WE, Resch K, Lovett DH.

Am J Physiol. 1992 Feb;262(2 Pt 1):C328-38.

PMID:
1539625
15.

Lipid A stimulates phospholipase D activity in rat mesangial cells via a G-protein.

Harrris WE, Bursten SL.

Biochem J. 1992 Feb 1;281 ( Pt 3):675-82.

16.
17.
18.

Rapid activation of phosphatidate phosphohydrolase in mesangial cells by lipid A.

Bursten SL, Harris WE.

Biochemistry. 1991 Jun 25;30(25):6195-203.

PMID:
1905569
19.

Activation of glomerular mesangial cells by gram-negative bacterial cell wall components.

Lovett DH, Bursten SL, Gemsa D, Bessler W, Resch K, Ryan JL.

Am J Pathol. 1988 Dec;133(3):472-84.

20.

Acylation of monocyte and glomerular mesangial cell proteins. Myristyl acylation of the interleukin 1 precursors.

Bursten SL, Locksley RM, Ryan JL, Lovett DH.

J Clin Invest. 1988 Nov;82(5):1479-88.

21.

Oral nifedipine for the treatment of patients with severe hypertension.

Davidson RC, Bursten SL, Keeley PA, Kenny MA, Stewart DK.

Am J Med. 1985 Oct 11;79(4A):26-30.

PMID:
3901748
22.

A clinical scoring system for detection of patients with pheochromocytomas.

Black HR, Bursten SL.

Yale J Biol Med. 1984 May-Jun;57(3):259-72.

23.

Supplemental Content

Loading ...
Support Center